CAD 0.03
(0.0%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -14.63 Million USD | -430.27% |
2022 | -992.78 Thousand USD | -133.22% |
2021 | 2.98 Million USD | 180.71% |
2020 | -3.75 Million USD | -112.82% |
2019 | -2.22 Million USD | -14.78% |
2018 | -1.51 Million USD | -338.18% |
2017 | -337.62 Thousand USD | 51.09% |
2016 | -123.82 Thousand USD | -3794.34% |
2015 | -131.41 Thousand USD | 94.49% |
2014 | -269.23 Thousand USD | -33.97% |
2013 | -310.54 Thousand USD | 60.03% |
2012 | -615.55 Thousand USD | -35.54% |
2011 | -454.13 Thousand USD | -185.75% |
2010 | -158.92 Thousand USD | -51.6% |
2009 | -104.83 Thousand USD | -5723.94% |
2008 | -1800.00 USD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | -653.4 Thousand USD | 29.47% |
2024 Q3 | -1.18 Million USD | -182.94% |
2024 Q1 | -801.73 Thousand USD | 48.12% |
2023 Q3 | -537.48 Thousand USD | 23.27% |
2023 FY | - USD | -430.27% |
2023 Q4 | -1.78 Million USD | -232.24% |
2023 Q1 | -1.02 Million USD | -20.14% |
2023 Q2 | -700.5 Thousand USD | 31.97% |
2022 Q2 | -328.59 Thousand USD | -137.84% |
2022 FY | - USD | -133.22% |
2022 Q4 | -857.11 Thousand USD | -26.9% |
2022 Q3 | -675.42 Thousand USD | -105.55% |
2022 Q1 | 868.34 Thousand USD | -32.33% |
2021 Q3 | 1.3 Million USD | 174.78% |
2021 Q4 | 1.28 Million USD | -1.49% |
2021 FY | - USD | 180.71% |
2021 Q1 | -71.67 Thousand USD | 91.14% |
2021 Q2 | 474.08 Thousand USD | 761.41% |
2020 Q1 | -1.16 Million USD | -29.87% |
2020 FY | - USD | -112.82% |
2020 Q4 | -808.65 Thousand USD | 31.49% |
2020 Q3 | -1.18 Million USD | -20.66% |
2020 Q2 | -978.21 Thousand USD | 15.74% |
2019 Q3 | 466.89 Thousand USD | 134.19% |
2019 Q4 | -893.94 Thousand USD | -291.47% |
2019 FY | - USD | -14.78% |
2019 Q1 | 131.99 Thousand USD | 209.3% |
2019 Q2 | -1.36 Million USD | -1134.47% |
2018 FY | - USD | -338.18% |
2018 Q4 | -120.76 Thousand USD | -2.97% |
2018 Q3 | -117.28 Thousand USD | 87.97% |
2018 Q2 | -974.73 Thousand USD | -221.77% |
2018 Q1 | -302.92 Thousand USD | -31.91% |
2017 Q2 | -39.33 Thousand USD | -166.11% |
2017 Q1 | 59.49 Thousand USD | 108.83% |
2017 Q4 | -229.63 Thousand USD | -68.31% |
2017 FY | - USD | 51.09% |
2017 Q3 | -136.43 Thousand USD | -246.9% |
2016 Q4 | -673.43 Thousand USD | -1187.9% |
2016 FY | - USD | -3794.34% |
2016 Q2 | -19.75 Thousand USD | -151.63% |
2016 Q3 | -52.28 Thousand USD | -164.7% |
2016 Q1 | 38.26 Thousand USD | 114.83% |
2015 Q2 | -21.49 Thousand USD | -185.21% |
2015 Q4 | 17.81 Thousand USD | 144.86% |
2015 FY | - USD | 94.49% |
2015 Q1 | 25.21 Thousand USD | 183.7% |
2015 Q3 | -39.69 Thousand USD | -84.73% |
2014 Q3 | -32.85 Thousand USD | 78.7% |
2014 FY | - USD | -33.97% |
2014 Q1 | -59.44 Thousand USD | -22.7% |
2014 Q2 | -154.22 Thousand USD | -159.44% |
2014 Q4 | -30.12 Thousand USD | 8.3% |
2013 Q1 | -107.74 Thousand USD | 73.59% |
2013 FY | - USD | 60.03% |
2013 Q4 | -48.44 Thousand USD | 42.3% |
2013 Q3 | -83.96 Thousand USD | -3.01% |
2013 Q2 | -81.51 Thousand USD | 24.35% |
2012 FY | - USD | -35.54% |
2012 Q3 | -166.73 Thousand USD | 0.19% |
2012 Q2 | -167.06 Thousand USD | 11.68% |
2012 Q1 | -189.15 Thousand USD | 32.92% |
2012 Q4 | -407.99 Thousand USD | -144.69% |
2011 Q1 | -19.65 Thousand USD | 57.08% |
2011 FY | - USD | -185.75% |
2011 Q3 | -93.68 Thousand USD | -59.22% |
2011 Q2 | -58.83 Thousand USD | -199.41% |
2011 Q4 | -281.97 Thousand USD | -200.99% |
2010 Q4 | -45.78 Thousand USD | 17.95% |
2010 Q3 | -55.8 Thousand USD | -95.85% |
2010 FY | - USD | -51.6% |
2010 Q1 | -28.83 Thousand USD | 18.87% |
2010 Q2 | -28.49 Thousand USD | 1.19% |
2009 Q1 | -34.59 Thousand USD | 0.0% |
2009 Q4 | -35.54 Thousand USD | -28.73% |
2009 Q2 | -25.66 Thousand USD | 25.82% |
2009 Q3 | -27.61 Thousand USD | -7.6% |
2009 FY | - USD | -5723.94% |
2008 FY | - USD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Aion Therapeutic Inc. | -6.07 Million CAD | -140.925% |
Ayurcann Holdings Corp. | -2.01 Million CAD | -627.834% |
Blueberries Medical Corp. | -1.22 Million CAD | -1097.674% |
The BC Bud Corporation | -1.19 Million CAD | -1123.485% |
BioNxt Solutions Inc. | -6.48 Million CAD | -125.658% |
CordovaCann Corp. | -1.6 Million CAD | -813.072% |
Christina Lake Cannabis Corp. | -2.62 Million CAD | -457.779% |
Captor Capital Corp. | 2.42 Million CAD | 704.379% |
City View Green Holdings Inc. | -2.01 Million CAD | -626.4% |
1CM Inc. | 1.31 Million CAD | 1214.028% |
Global Hemp Group Inc. | -24.79 Thousand CAD | -58920.901% |
Greenway Greenhouse Cannabis Corporation | -2.2 Million CAD | -562.611% |
IM Cannabis Corp. | -2.79 Million CAD | -424.482% |
Lobe Sciences Ltd. | -4.4 Million CAD | -232.397% |
Maple Leaf Green World Inc. | -392.21 Thousand CAD | -3630.866% |
Mountain Valley MD Holdings Inc. | -3.19 Million CAD | -358.285% |
Nextleaf Solutions Ltd. | 1.14 Million CAD | 1381.801% |
Ovation Science Inc. | -778.83 Thousand CAD | -1778.846% |
Pharmadrug Inc. | -1.33 Million CAD | -996.098% |
Captiva Verde Wellness Corp. | -6.05 Million CAD | -141.626% |
RAMM Pharma Corp. | -6.3 Million CAD | -132.194% |
RIV Capital Inc. | -20.28 Million CAD | 27.846% |
Revive Therapeutics Ltd. | -5.59 Million CAD | -161.538% |
Red White & Bloom Brands Inc. | -77.59 Million CAD | 81.141% |
SLANG Worldwide Inc. | -2.95 Million CAD | -395.915% |
1933 Industries Inc. | -10.03 Million CAD | -45.85% |
Red Light Holland Corp. | -5.25 Million CAD | -178.414% |
Top Strike Resources Corp. | -767.99 Thousand CAD | -1805.363% |
Xebra Brands Ltd. | -1.49 Million CAD | -878.802% |
Adastra Holdings Ltd. | -1.41 Million CAD | -936.876% |